The U.S. government is using stockpiles of raw drug ingredients and new AI tools to fight drug shortages, but critics say these measures don't fix the broken system behind them. Hospitals are overwhelmed, patients are skipping doses, and funding cuts are making it worse.
Read More
DMARD and Biologic Interactions: Managing Rheumatoid Arthritis Medications Safely
Cold and Flu Medications While Pregnant: Safe Options vs. What to Avoid
False advertising in generics: legal risks and rules
Biosimilar Switching: What Happens When You Change from Originator
Cetirizine vs Fexofenadine: Which Antihistamine Has Fewer Side Effects?
